Open Access

A case report of metastasis of malignant mesothelioma to the oral gingiva

  • Stephanie Moser1Email author,
  • Marc Beer1,
  • Georg Damerau1,
  • Heinz-Theo Lübbers1,
  • Klaus W Grätz1 and
  • Astrid L Kruse1
Head & Neck Oncology20113:21

DOI: 10.1186/1758-3284-3-21

Received: 17 March 2011

Accepted: 22 April 2011

Published: 22 April 2011

Abstract

Introduction

Metastatic mesothelioma to the oral cavity arises from the pleura or peritoneum and distant hematogenous metastases are seen in more than half of cases but only a few cases are reported to the oral cavity.

Case

A 75 year old male suffering from metastatic mesothelioma presents an hyperplasia of the attached gingiva. Malignant mesothelioma is a rare tumour arising from pleura, pericardium or peritoneum.

Conclusion

This article highlights the importance of biopsy and histopathological diagnosis of oral lesions especially in case of a malignant history.

Keywords

Mesothelioma metastasis soft tissue

Introduction

Malignant pleural mesothelioma is a malignant neoplasm of mesodermal origin and arises from multipotential mesothelial or subserosal cells of the pleura, pericardium and peritoneum. There are different forms: epitheloid (60%), sarcomatoid (10-20%) and biphasic patterns (20-30%). Metastases to the oral cavity are very rare [1, 2]. They are more common in the jaw bones than the soft tissue. The most common sites for men are the lungs ( 27%), kidneys (13%) and skin (13%) - for women, the breast (24%) and genital organs (17%), followed by bone (10%) and kidney (10%) [1]. The reason for this gender-dependent metastatic pattern has not completely been elucidated yet. In 90% of all pleural mesothelioma, asbestos-association due to occupational exposure is reported. The tumour is found in patients in the fifth and sixth decades. The latency between exposure and manifestation takes approximately 20-40 years. Occurrence of the malignant disease typically carries an average survival rate of 9-12 months [3].

A patient with a history of malignant pleural mesothelioma with metastatic disease to the attached gingiva is presented.

Patient

A 75-year-old man was referred from his private dentist to the Department of Oral Surgery, University of Zurich with a painless growth of the attached gingiva in the disto-buccal region of tooth 35. It had been present for 6 weeks and had increased in size during this period of time.

An epitheloid mesothelioma was diagnosed 2 years earlier (Figure 1) and treated with chemotherapy. The patient commenced the drug Alimta® (Pemetrexed) with palliative intent. He had had a significant asbestos exposure during his working life as an electrician. His medical history was otherwise unremarkable. He was a non-smoker.
Figure 1

Chest CT presenting the mesothelioma

Extraorally, neither swelling nor lymphadenopathy was discernible. The innervation of the N.trigeminus was balanced on both sides. Oral examination showed an exophytic, compact and in parts ulcerous swelling surrounding the premolar tooth 35 (Figure 2). The lesion measured approximately 1.5 cm by 1.0 cm. The affected tooth was of grade one mobility, no pathological results in sensitivity and percussion were found and there was no objective paraesthesia in the distribution of the left mental nerve.
Figure 2

Hyperplasia of the attached gingiva showing the soft tissue metastasis

Radiological examination (orthopantomogram and digital volume tomography) of the lower jaw revealed no destruction of the bony architecture (Figure 3, 4). There were no changes to the structure of the compacta or spongiosa.
Figure 3

Orthopantomogram is showing no bony destruction

Figure 4

Digital volume tomography sagittal is showing no changings in bony architecture

An incisional spindle-shaped biopsy with a thread-mark was carried out under local anaesthesia. The sample measured 10 × 5 mm including both normal and modified gingiva. During the biopsy an unusual blood flow was conspicuous. The second premolar was not extracted.

Histology and immunohistochemistry confirmed the diagnosis of a metastasis of the pleural mesothelioma.

Diagnostic considerations

Clinically, soft tissue metastases typically present as sessile or nodular masses that characteristically resemble hyperplastic reactive lesions, such as pyogenic granuloma or giant cell granuloma [4]. Differential diagnosis, such as other benign tumours of the oral mucosa including lipoma, myxoma, neurofibroma, schwannoma, leiomyoma and various forms of epulis, have to be considered. Murray et al. [5] reported a case where the clinical appearance was most suggestive of a fibroepithelial polyp localized on the dorsum of the tongue. Therefore, excisional biopsy of the lesion was arranged to confirm the diagnosis histologically.

Histology

Grossly, the specimen was a polypous lesion measuring 0,5 × 0,4 cm, protruding from a mucous membrane spindle with a white cut face.

On microscopy, a submucous infiltrate of a neoplasm with marked cell atypia and a glandular growth pattern was seen (Figure 5 & 6).
Figure 5

Conventional H&E morphology (50× and 100×) showing squamous mucosa with tubular tumour infiltrates.

Figure 6

Conventional H&E morphology (50× and 100×) showing squamous mucosa with tubular tumour infiltrates.

In comparison, the pleural biopsy taken two years previously, when malignant mesothelioma was originally diagnosed in the patient, showed very similar cytology but a more trabecular architecture with only occasional tubular formations (Figure 7).
Figure 7

Conventional H&E (100×) morphology of pleural Biopsy taken in 2008 showing an infiltrate with a trabecular architecture.

Conventional morphology ruled out clinical differential diagnoses such as pyogenic granuloma, epulis, drug-induced gingival hyperplasia or soft tissue tumours.

Likely differentials were metastasis of epitheloid mesothelioma or adenocarcinoma, primarily of the lung.

Calretinin, a mesothelial marker turned out to be strongly positive in tumour cells on immunohistochemical staining (Figure 8), substantiating diagnosis of an epitheloid mesothelioma metastasis. Positive staining for cytokeratins 5/6 and negative staining for Ber-EP4 further helped to distinguish it from adenocarcinoma.
Figure 8

Calretinine stain (50×), strong positivity of the tumour cells for this mesothelial marker.

Discussion

Metastases of a malignant mesothelioma are very rare but have previously been described. An English literature review (Table 1) revealed six cases on the tongue, four (including the present report) the attached gingiva, one case the bone and one the floor of the mouth in only male patients with a previous diagnosis of mesothelioma. The median age was 61.25 years with a median time from diagnosis to development of the oral metastasis was 12.4 months.
Table 1

Reported cases of soft tissue metastases in mesothelioma (1993 - 2010)

Case

Age at time of occurence

Sex

Previous/existing diagnosis of mesothelioma

Site of primary mesothelioma

time from diagnosis to development of oral metastasis in months

Localisation

Publication

      

Tongue

 

1

73

m

Yes

Pleural

24

right lateral

1993 [13]

2

52

m

Yes

Pleural

24

right lateral

2003 [14]

3

71

m

Yes

Pleural

14

right lateral

2003 [15]

4

70

m

Yes

Pleural

9

left lateral

2005 [4]

5

68

m

Yes

Pleural

5

anterior central

2007 [16]

6

46

 

Yes

Pleural

8

dorsum

2010 [5]

      

attached gingiva

 

1

45

m

Yes

Pleural

12

lingual 36

1993 [13]

2

48

m

Yes

Pleural

4

regio 35-36

1993 [17]

3

63

m

Yes

Pleural

11

regio 35 buccal

2002 [8]

4

75

m

Yes

Pleural

24

regio 35 buccal

2010current report

      

Bone metastasis

 

1

53

m

Yes

Pleural

2

regio 38

2003 [7]

      

Floor of mouth

 

1

71

m

Yes

Pleural

12

right

2010 [18]

Metastatic tumours to the oral cavity and jaws are uncommon lesions and represent about 1% of all metastases in humans. Primary breast carcinomas are the most common types of tumour to metastasize to the jaw bones while primary lung carcinomas are the most common types of tumour to metastasize to the oral soft tissue [6]. These oral metastases represent about 1% of oral malignances and there are more cases reported arising in the jaw bones than in the oral soft tissues with a ratio of approximately 2:1 [7]. Most of the soft tissue metastases occur on the gingiva and alveolar mucosa, with an additional 27% involving the tongue. It seems that the presence of teeth has a crucial effect on the oral site preference of metastases. In dentulous patients, 79% exhibited their metastases in the attached gingiva, whereas in edentulous patients, metastastic lesions were equally distributed between the tongue and alveolar mucosa [8]. In this case, the primary tumour was histologically classified as an epitheloid type. Law et al. reported that the epithelial type has a tendency to invade directly and cause lymphatic metastases similar to carcinoma, whereas the sarcomatous type tends to metastasize hematogenously like sarcoma [7].

Only a small number of reports for metastases in the oral cavity of a malignant pleura mesothelioma were found in the literature (Table 1). 12 cases were found in all. The age-range of the male-only patients is 45 - 75. The tongue (6 cases) seems to be the preferred site for metastases, followed by the attached gingiva (4 cases) and only 1 case is published which affects either the lower jaw or the floor of the mouth. One possible explanation for the tendency towards the tongue and the attached gingiva might be the rich capillary network, especially where chronically inflamed gingiva trap malignant cells and the fragmented basement membranes of proliferation capillaries allow easier penetration by malignant cells than in more mature blood vessels [9]. The tongue also is well vascularized and it has been postulated that this may provide a good setting for malignant cells [10].

Several differential diagnosis should be taken into consideration. An enlargement or overgrowth of the gingiva is a recognized complication that has been associated with the administration of phenytoin, some calcium channel blockers, and cyclosporine [11]. However, in most of these cases, hyperplasia is general rather than localized, although there are still exceptions.

As with the present patient, pemetrexed with a platinum agent is the regime of first choice in chemotherapy for mesothelioma [12]. There are many known side effects, but no publication was found which describes an effect to the oral soft tissue.

This article highlights the importance of biopsy and histopathological diagnosis of oral lesions especially in case of a malignant history. Furthermore, a regular screening for oral neoplasms is indispensable. Prognosis for patients with malignant mesothelioma is very poor. The majority of patients are incurable and the treatment is aimed at palliation. Having consulted our patient's oncologist, one decided to limit the therapy to regular recalls and an alteration of the chemotherapy drugs but to avoid surgical treatment with resection of the tumour because of reduced life expectancy.

Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Declarations

Authors’ Affiliations

(1)
Department of Craniomaxillofacial and Oral Surgery, University Hospital Zurich

References

  1. Hirshberg A, Leibovich P, Buchner A: Metastases to the oral mucosa: Analisis of 157 cases. J Oral Pathol Med. 1993, 22: 385m-10.1111/j.1600-0714.1993.tb00128.x.View ArticleGoogle Scholar
  2. Aguirre A, Rinaggio J, Diaz-Ordaz E: Lingual metastasis of renal cell carcinoma. J Oral Maxillofac Surg. 1996, 54: 344-10.1016/S0278-2391(96)90757-0.View ArticlePubMedGoogle Scholar
  3. Müller KM: Pleuramesotheliom - Pathologie und Pathogenese Pneumologie. 2004, 58: 670-679.Google Scholar
  4. Tho LM, O`Rourke NP: Unsusual metastases from malignant pleural mesothelioma. Clin Oncol. 2005, 17: 293-10.1016/j.clon.2004.07.017.View ArticleGoogle Scholar
  5. Murray LJ, Higham J, et al: Oral presentation of malignant mesothelioma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010Google Scholar
  6. Kruse A, Luebbers HT, Obwegeser J, Edelmann L, Grätz KW: Temporomandibular disorders associated with metastases to the temporomandibular joint: a review of the literature and 3 additional cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010, 110: e21-e28.View ArticlePubMedGoogle Scholar
  7. Terakado N, Shintani S, et al: Malignant pleural mesothelioma metastasis to the mandible. Int J Oral Maxillofac Surg. 2004, 33: 798.800-View ArticlePubMedGoogle Scholar
  8. Garcia-Reija M, Mtilla JM, et al: Unusual metastasis to the mandibular alveolus of a malignant pleural mesothelioma. Otolaryngol Head Neck Surg. 2002, 126: 435-7. 10.1067/mhn.2002.123921.View ArticlePubMedGoogle Scholar
  9. Nagy JA, Brown LF, Senger DR, Lanir N, Van de Water L, Dvorak HF, et al: Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochem Biophys Acta. 1989, 948: 305-6.PubMedGoogle Scholar
  10. Hirschberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R: Metastatic tumors to the oral cavity- pathogenesis and analysis of 673 cases. Oral Oncol. 2008, 44: 743-52. 10.1016/j.oraloncology.2007.09.012.View ArticleGoogle Scholar
  11. Guggenheimer J: Oral manifestations of drug therapy. Cent Clin North Am. 2002, 46 (4): 857-68. 10.1016/S0011-8532(02)00024-1.View ArticleGoogle Scholar
  12. Rudd RM, et al: Malignant Mesothelioma. Br Med Bull. 2010, 93 (1): 105-123. 10.1093/bmb/ldp047.View ArticlePubMedGoogle Scholar
  13. Kerpel SM, Freedman PD: Metastatic mesothelioma of the oral cavity Report of two cases. Oral Surg Oral Med Oral Pathol. 1993, 76: 746-51. 10.1016/0030-4220(93)90046-7.View ArticlePubMedGoogle Scholar
  14. Cassarino DS, Xue W, Shannon KJ: Widespread cutaneous and perioral metastases from malignant pleural mesothelioma. J Clin Oncol. 2003, 30: 582-5.Google Scholar
  15. Zanconati F, DelConte A, Bonifacio-Gori D, Falconieri G: Metastatic pleural mesothelioma presenting with solitary involvement of the tongue. Report of a new case and review of the literature. Int J Surg Pathol. 2003, 11: 51-5. 10.1177/106689690301100114.View ArticlePubMedGoogle Scholar
  16. Higginson DS, Brahmer J, Tufano RP, Bajaj GK: Pleural mesothelioma metastatic to tongue. J Clin Oncol. 2007, 25: 133-9.View ArticleGoogle Scholar
  17. Sproat CP, Brown AE, Lindly RP: Oral metastasis in malignant pleural mesothelioma. Br J Oral Maxillofac Surg. 1993, 31 (5): 316-7. 10.1016/0266-4356(93)90069-9.View ArticlePubMedGoogle Scholar
  18. Kirke D, Horwood K, Wallwork B: Floor of mouth and tongue metastasis from malignant pleural mesothelioma. ANZ J Surg. 2010, 80 (7-8): 556-8. 10.1111/j.1445-2197.2010.05383.x.View ArticlePubMedGoogle Scholar

Copyright

© Moser et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement